Literature DB >> 12914221

[Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site].

Shiyong Liu1, Jianfeng Pei, Hao Chen, Xiaolei Zhu, Zhenming Liu, Wenzhe Ma, Fenglei He, Luhua Lai.   

Abstract

SARS coronavirus 3CL proteinase is the key enzyme for virus replication which may serve as the target for drug discovery against SARS. A 3D structure model has been built for SARS coronavirus 3CL proteinase by comparative protein modeling. A homodimer model of the proteinase was also built. Analysis of the dimeric interface suggests the 3CL proteinase may have dimer form in solution. The conformational flexibility of the active site has been simulated by molecular dynamics combined with multi-canonical sampling. The active site loops have two typical conformations which may be related to the conformational movement associated with the enzymatic reaction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12914221

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  4 in total

1.  The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.

Authors:  Li Ding; Xin-Xiang Zhang; Ping Wei; Keqiang Fan; Luhua Lai
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

2.  A classification of countries and regions by degree of the spread of coronavirus based on statistical criteria.

Authors:  Antoni Wilinski; Eryk Szwarc
Journal:  Expert Syst Appl       Date:  2021-02-01       Impact factor: 6.954

3.  Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus.

Authors:  Guang Wu; Shaomin Yan
Journal:  Peptides       Date:  2004-06       Impact factor: 3.750

4.  Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase.

Authors:  Keqiang Fan; Ping Wei; Qian Feng; Sidi Chen; Changkang Huang; Liang Ma; Bing Lai; Jianfeng Pei; Ying Liu; Jianguo Chen; Luhua Lai
Journal:  J Biol Chem       Date:  2003-10-15       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.